Components of the NLRP3 inflammasome complex and proinflammatory markers were analyzed in livers to test whether NPRP3 inflammasome and related hepatic metaflammation participate in verapamil-mediated improvements in hepatic steatosis and insulin resistance. This evidence concerns the gene NLRP3 and fatty liver disease.